Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PIP4K2A/2B inhibitor suppresses tumor growth in a xenograft model of NSCLC.

iScience·2026
Same author

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Differential assembly of mouse and human tumor microenvironments.

Nature immunology·2026
Same author

Prevalence of <i>BRCA1</i> Promoter Methylation in Cohorts of Individuals With and Without Cancer Assessed by Circulating Cell-Free DNA.

JCO precision oncology·2026
Same author

Defective BRCA1-mediated DNA end resection drives tandem duplication formation and <i>FANCM</i> synthetic lethality.

bioRxiv : the preprint server for biology·2026
Same author

Prediction of outcome from spatial Protein profiling of triple-negative breast cancers.

Communications medicine·2026
Same journal

Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers.

Trends in cancer·2026
Same journal

Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals.

Trends in cancer·2026
Same journal

Precision neuro-oncology for children: Time to gear up!

Trends in cancer·2026
Same journal

Multi-omics analysis of extracellular vesicle cargo in cancer.

Trends in cancer·2026
Same journal

An immunological panacea for cancer-related cachexia.

Trends in cancer·2026
Same journal

Beyond one gene, one target: Next-generation precision oncology.

Trends in cancer·2026
See all related articles

Related Experiment Video

Updated: Aug 2, 2025

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.6K

Mouse models for immuno-oncology.

Marcus Bosenberg1, Edison T Liu2, Chun I Yu2

  • 1Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.

Trends in Cancer
|April 22, 2023
PubMed
Summary
This summary is machine-generated.

Understanding in vivo mechanisms is crucial for advancing cancer immunotherapy. Preclinical mouse models are vital for studying treatment responses and toxicities, but require further development.

Keywords:
cancer immunotherapycollaborative cross micediversity outbred micegenetically engineered micehumanized micemouse model

More Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Related Experiment Videos

Last Updated: Aug 2, 2025

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
08:17

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

14.6K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

Area of Science:

  • Immunology
  • Oncology
  • Preclinical Research

Background:

  • Clinical success of cancer immunotherapy is limited by incomplete understanding of in vivo treatment response and toxicity mechanisms.
  • Effective preclinical models are essential to bridge this knowledge gap for advancing cancer immunotherapy.

Purpose of the Study:

  • To review the advantages and limitations of current in vivo preclinical models for cancer immunotherapy research.
  • To discuss future developments in preclinical model systems for immunotherapy.

Main Methods:

  • Literature review and discussion of existing preclinical in vivo model systems.
  • Analysis of mouse models commonly used in cancer immunotherapy research.

Main Results:

  • Mice are frequently utilized in basic and translational research for immune interventions in cancer.
  • Current models offer benefits but also possess limitations that need addressing for improved immunotherapy development.

Conclusions:

  • Further development of preclinical in vivo models is necessary to overcome challenges in clinical cancer immunotherapy.
  • Advanced model systems are key to realizing the full clinical potential of cancer treatments targeting the immune system.